| Literature DB >> 29237794 |
Ryan R Walsh1, Florian Krismer2, Wendy R Galpern2, Gregor K Wenning2, Phillip A Low2, Glenda Halliday2, Walter J Koroshetz2, Janice Holton2, Niall P Quinn2, Olivier Rascol2, Leslie M Shaw2, David Eidelberg2, Pam Bower2, Jeffrey L Cummings2, Victor Abler2, Judy Biedenharn2, Gal Bitan2, David J Brooks2, Patrik Brundin2, Hubert Fernandez2, Philip Fortier2, Roy Freeman2, Thomas Gasser2, Art Hewitt2, Günter U Höglinger2, Matt J Huentelman2, Poul H Jensen2, Andreas Jeromin2, Un Jung Kang2, Horacio Kaufmann2, Lawrence Kellerman2, Vikram Khurana2, Thomas Klockgether2, Woojin Scott Kim2, Carol Langer2, Peter LeWitt2, Eliezer Masliah2, Wassilios Meissner2, Ronald Melki2, Susanne Ostrowitzki2, Steven Piantadosi2, Werner Poewe2, David Robertson2, Cyndi Roemer2, Dale Schenk2, Michael Schlossmacher2, Jeremy D Schmahmann2, Klaus Seppi2, Lily Shih2, Andrew Siderowf2, Glenn T Stebbins2, Nadia Stefanova2, Shoji Tsuji2, Sharon Sutton2, Jing Zhang2.
Abstract
Multiple system atrophy (MSA) is a rare neurodegenerative disorder with substantial knowledge gaps despite recent gains in basic and clinical research. In order to make further advances, concerted international collaboration is vital. In 2014, an international meeting involving leaders in the field and MSA advocacy groups was convened in Las Vegas, Nevada, to identify critical research areas where consensus and progress was needed to improve understanding, diagnosis, and treatment of the disease. Eight topic areas were defined: pathogenesis, preclinical modeling, target identification, endophenotyping, clinical measures, imaging biomarkers, nonimaging biomarkers, treatments/trial designs, and patient advocacy. For each topic area, an expert served as a working group chair and each working group developed priority-ranked research recommendations with associated timelines and pathways to reach the intended goals. In this report, each groups' recommendations are provided.Entities:
Mesh:
Year: 2017 PMID: 29237794 PMCID: PMC5772155 DOI: 10.1212/WNL.0000000000004798
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910